Cigna Group (NYSE:CI) Hits New 52-Week High – Should You Buy?

Cigna Group (NYSE:CI) hit a new 52-week high on Thursday. The company traded as high as $311.98 and last traded at $312.3050, with a volume of 294,103 shares. The stock had previously closed at $304.37.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CI. Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Royal Bank Of Canada reissued an “outperform” rating and set a $337.00 target price on shares of Cigna Group in a report on Thursday, October 1st. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their target price for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $338.24.

Cigna Group Stock Performance

The stock has a 50 day moving average of $281.72 and a 200 day moving average of $283.21. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $81.10 billion, a price-to-earnings ratio of 12.70, a P/E/G ratio of 1.07 and a beta of 0.29.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts anticipate that Cigna Group will post 30.50 EPS for the current fiscal year.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 22,730 shares of company stock worth $6,293,359 over the last three months. 0.60% of the stock is currently owned by insiders.

Institutional Trading of Cigna Group

Several large investors have recently bought and sold shares of the business. BlackRock Inc. boosted its stake in Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. GQG Partners LLC bought a new stake in Cigna Group during the 2nd quarter worth approximately $1,628,918,000. Bank of America Corp DE raised its stake in shares of Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after purchasing an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Cigna Group by 10.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after purchasing an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc bought a new position in shares of Cigna Group in the second quarter valued at approximately $542,779,000. 86.99% of the stock is owned by institutional investors and hedge funds.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.